Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

An unlikely new weapon against a deadly bacteria in oysters: A virus

19.12.2002


People looking forward to eating raw oysters over the holidays will welcome news that scientists are making progress in the fight against a rare but deadly disease associated with the tasty bivalves.

Two University of Florida researchers report curing mice of the disease by using a virus to attack its bacterial source – Vibrio vulnificus. The scientists say the research may lead to techniques to purify oysters after harvest but before they reach raw bars and seafood markets – and might one day result in a better cure for the disease in people.

The work, reported in a November article in the journal Infection and Immunity, is part of a growing trend in research to use bacteria-attacking viruses, or "phages," to cure diseases caused by bacteria, said Paul Gulig, a UF professor of molecular genetics and microbiology at UF’s College of Medicine. Although the disease caused by Vibrio responds to antibiotic treatment if caught early enough, the trend toward research of phages is spurred in part by the increasing ineffectiveness of antibiotics in killing ever-more-resistant bacteria, he and other researchers said.



"Phages haven’t been used in the United States since the early 20th century because antibiotics have worked pretty well," he said. "That’s changing now, and there is more interest in investigating the phage alternative."

Vibrio vulnificus is related to the cholera bacterium and occurs naturally in the presence of microscopic algae in seawater. When oysters eat the algae, Vibrio becomes concentrated. People can come into contact with the bacterium by eating raw oysters (cooking the bivalves kills the bacterium), or by exposing an open wound to water or mud where the bacterium is present.

Most exposed people suffer no ill effects because their bodies easily fight off the bacterium. However, people who suffer from liver damage – from alcohol-related cirrhosis, for example – may become infected. There are 30 to 50 cases of Vibrio vulnificus disease reported annually in the United States. Although rare, the disease is severe and often fatal, killing between 50 percent and 75 percent of those who are infected. The bacterium causes flu-like symptoms, followed by high fever, shock and half-dollar sized blood blisters mostly on the patient’s legs.

Gulig and Donna Duckworth, a professor of molecular genetics and microbiology and co-author of the article, said because Vibrio resembles the flu or less-harmful diseases, it often remains undiagnosed until its later stages. At that point, the disease does not respond well to antibiotics, whence its high mortality rate, they said. Seeking an alternative to antibiotics, he and Duckworth decided to test the effectiveness of phages in attacking the disease.

The scientists isolated phages that prey naturally on the bacterium from oysters purchased from seafood markets and in mud collected from oyster beds in Florida’s coastal waters. They grew the phages in the laboratory, then injected solutions containing concentrated amounts of the virus into the tail veins of mice infected with Vibrio. The result: The researchers found the phages cured the mice even well after they had begun experiencing symptoms of the disease.

"It was very clear that the phage treatment for many of the mice could completely protect them. It could prevent death, and it could essentially clear the mice of bacteria," Gulig said. "We showed that, in typical infections of mice, we get 100 million bacteria per gram of tissue, and in these treated mice we essentially could not detect any bacteria at all."

Gulig said the project didn’t compare the phages with similarly timed antibiotic treatments, so the researchers couldn’t say which is more effective. But phages have some tantalizing advantages over antibiotics, he said. While antibiotics naturally become diluted and leave the body after a period of time, phages grow and multiply until they have preyed on all the available bacteria, he said. Also, antibiotics are general treatments, killing harmful bacteria as well beneficial organisms, making patients vulnerable to yeast infections and other maladies. Phages, by contrast, are extremely specific, with the virus seeking only its natural prey and thus causing no unexpected outcomes.

The research was funded with a $64,000 grant from the U.S. Department of Commerce SeaGrant Program. The agency has awarded the scientists, in collaboration with Anita Wright, a UF assistant professor of food science and human nutrition, an additional $144,000 to pursue a new direction: using phages to purify oysters before they reach consumers. The idea would be to submerge the harvested oysters in vats of phage-treated water, allowing them to filter in the phage and kill off the Vibrio vulnificus before the oysters reach the market. Such technology would be quicker and cheaper to develop and commercialize than a new treatment for Vibrio disease, because it wouldn’t have to meet regulatory standards for human medicine, Gulig said. "It would be a truly natural treatment, since we’re essentially treating the oysters with something they’re already exposed to in the wild," Gulig said.

Alexander Sulakvelidze, an assistant professor of microbiology and epidemiology at the University of Maryland, said the method appears promising.

"There are a number of approaches that allow you to clear oysters of Vibrio vulnificus, and none of them are optimal," Sulakvelidze said.

"They are very expensive or not very applicable for treating live oysters, so this may provide an additional tool to improve the safety of oysters."

Another goal of the UF research is to determine if phages can be used in a topical skin cream to help prevent contraction of Vibrio through skin wounds. "One thing we’ve thought about is having little vials of phage that fishermen can use prophylactically as soon as they get cut," Duckworth said.



Writer: Aaron Hoover
ahoover@ufl.edu
Sources: Paul Gulig, Donna Duckworth
352-392-0050, 352-392-0681
gulig@ufl.edu, duckwort@mgm.ufl.edu


Aaron Hoover | EurekAlert!
Further information:
http://www.ufl.edu/

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>